L. Wang
Chinese Academy of Medical Sciences & Peking Union Medical College
ORCID: 0009-0008-9180-0981Also affiliated with Peking Union Medical College Hospital
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “A phase II study of GW786034 (pazopanib) in patients with recurrent or metastatic invasive breast carcinoma: Results after completion of stage I: A trial of the Princess Margaret Hospital Phase II Consortium”.
S. Chia, S. Dent, M. Clemons, P. Grenci, L. Wang +5 more
Y. Lu, E. Y. Lai, J. Wei, L. Wang, K. Chandrashekar +5 more
C.M. Hutter, C.S. Shelley, Y. Newton, Sheen Tickoo, N. Schultz +46 more
M. Xu, C. Zhang, L. Wang
S.C. Jha, Haoyong Zhu, J.H. Gilmore, F. Zou, Gang Li +9 more
D. Barch, M. Styner, J.A. Lieberman, D. Mamah, Michele Harms +1 more
L. Wang, X. Chen